Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunshine Biopharma Inc.

1.23
-0.0400-3.15%
Pre-market: 1.20-0.0297-2.41%08:56 EDT
Volume:209.05K
Turnover:260.04K
Market Cap:4.79M
PE:-0.17
High:1.31
Open:1.27
Low:1.21
Close:1.27
Loading ...
Feb 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 08, 2022

Major Issues Report

8-K - Current report
Feb 03, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 24, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 19, 2020

Major Issues Report

8-K - Current report
Sep 15, 2020

Major Issues Report

8-K - Current report
Aug 31, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
May 18, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]